What is Fulgent Genetics, Inc.'s revenue?

Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.

Is Fulgent Genetics, Inc. profitable?

Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.

What are Fulgent Genetics, Inc.'s profit margins?

Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.

What is Fulgent Genetics, Inc.'s earnings per share?

Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.

Where does Fulgent Genetics, Inc.'s income statement data come from?

Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Fulgent Genetics, Inc. FLGT Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$322.67M+13.8%	$283.47M-2.0%	$289.21M-53.3%	$618.97M-37.6%
Total cost of revenue	$191.8M+8.8%	$176.26M-4.6%	$184.76M-26.7%	$252.07M+17.0%
Gross profit	$130.88M+22.1%	$107.22M+2.6%	$104.46M-71.5%	$366.9M-52.8%
Gross margin	40.6%+2.7pp	37.8%+1.7pp	36.1%-23.2pp	59.3%-19.0pp
Research and development	$53.91M+10.4%	$48.82M+17.8%	$41.44M+43.3%	$28.91M+19.4%
Selling and marketing	$43.37M+19.7%	$36.25M-12.6%	$41.47M+6.5%	$38.92M+59.2%
General and administrative	$116.66M+32.4%	$88.11M-1.0%	$89M-19.9%	$111.07M+119%
Depreciation and amortization	$8.03M+0.8%	$7.97M+1.5%	$7.85M-23.7%	$10.29M+70.1%
Goodwill impairment	$0—	$0—	——	——
Other operating expenses	$221.97M+22.5%	$181.13M-39.6%	$299.99M+59.2%	$188.37M+86.3%
Total operating expenses	$221.97M+22.5%	$181.13M-39.6%	$299.99M+59.2%	$188.37M+86.3%
Operating income	-$91.1M-23.2%	-$73.92M+62.2%	-$195.53M-210%	$178.53M-73.6%
Operating margin	-28.2%-2.2pp	-26.1%+41.5pp	-67.6%-96.4pp	28.8%-39.3pp
Interest expense	$75K—	——	——	$1.01M—
Interest income	$30.92M-1.2%	$31.3M+48.0%	$21.16M+276%	$5.62M+307%
Other income (expense), net	$21.07M-4.0%	$21.95M—	——	$5.5M—
Income before income taxes	-$70.03M-34.8%	-$51.96M+70.2%	-$174.09M-195%	$184.03M-72.8%
Income tax expense	-$8.39M-3.1%	-$8.14M—	——	$42.1M-75.9%
Net income	-$60.51M-41.7%	-$42.71M+74.6%	-$167.83M-217%	$143.4M-71.7%
Net margin	-18.8%-3.7pp	-15.1%+43.0pp	-58%-81.2pp	23.2%-27.9pp
Diluted earnings per share	-$1.96-39.0%	-$1.41+75.0%	-$5.64-224%	$4.56-72.2%
Basic earnings per share	-$1.96-39.0%	-$1.41+75.0%	-$5.64-219%	$4.73-72.7%
Weighted-average shares, diluted	122.9M+2.0%	120.5M+1.2%	119.1M-4.1%	124.3M+0.4%
Weighted-average shares, basic	122.9M+2.0%	120.5M+1.2%	119.1M-1.4%	120.9M+3.3%
Continuing operations (in dollars per share)	-$1.96-39.0%	-$1.41+75.0%	-$5.64-219%	$4.73-72.7%
Continuing operations (in dollars per share)	-$1.96-39.0%	-$1.41+75.0%	-$5.64-224%	$4.56-72.2%
Amortization of capitalized software and acquired intangible assets	$8.03M+0.8%	$7.97M+1.5%	$7.85M+20.7%	$6.5M—
Deferred taxes	-$1.21M+67.5%	-$3.74M-133%	$11.47M—	——
Finance Lease Principal Payments	$399K-26.7%	$544K-25.5%	$730K+4.3%	$700K—
Gain/(loss) on dispositions, net	——	-$331K—	——	-$511K+39.9%
Goodwill impairment losses	$0—	$0—	——	——
Accounts payable	$550K—	——	-$7.03M—	——
Increase (Decrease) in Accounts Receivable	——	$16.3M—	——	-$68.64M—
Increase in accrued expenses and other liabilities	$8.91M—	——	$2.72M—	——
Increase (Decrease) in Other Operating Assets	——	-$199K—	——	-$9.38M—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$14.79M-205%	-$4.85M+89.9%	-$47.79M+38.1%	-$77.14M-187%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	$111.37M—	——	$38.9M—	——
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	——	$21.06M-22.0%	$27M-89.3%	$253.52M-52.9%
Other Noncash Income (Expense)	——	——	——	——
Other income, net (Note 6)	$153K-72.3%	$553K—	——	$887K—
Payments for Repurchase of Common Stock	——	——	——	——
Payment, Tax Withholding, Share-Based Payment Arrangement	$3.04M+4.7%	$2.9M+6.1%	$2.73M+54.5%	$1.77M-57.4%
Payments to Acquire Businesses, Net of Cash Acquired	——	$0-100%	$399K—	——
Payments to Acquire Property, Plant, and Equipment	$22.57M-44.0%	$40.32M+81.5%	$22.21M+18.3%	$18.78M-21.2%
Dispositions of property, plant, and equipment	——	$313K-59.6%	$775K+88.1%	$412K+554%
Cash received from option exercises	——	$51K+1,600%	$3K-90.3%	$31K-64.0%
Net additions (releases) charged to costs and expenses	$7.65M—	——	——	$32.61M+265%
Revenue From Contract With Customer Excluding Assessed Tax	$322.67M+13.8%	$283.47M-2.0%	$289.21M-53.3%	$618.97M-37.6%
Stock-based compensation	$39.58M-11.0%	$44.48M+3.6%	$42.92M+31.5%	$32.64M+106%
EBIT	-$91.1M-23.2%	-$73.92M+62.2%	-$195.53M-210%	$178.53M-73.6%
EBITDA	-$66.97M-36.7%	-$48.99M+71.1%	-$169.39M-180%	$211.19M-69.3%
EBITDA	-$66.97M-36.7%	-$48.99M+71.1%	-$169.39M-180%	$211.19M-69.3%
EBITDA margin	-20.8%-3.5pp	-17.3%+41.3pp	-58.6%-92.7pp	34.1%-35.1pp
EBIT	-$91.1M-23.2%	-$73.92M+62.2%	-$195.53M-210%	$178.53M-73.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Fulgent Genetics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s revenue?: Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
Is Fulgent Genetics, Inc. profitable?: Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
What are Fulgent Genetics, Inc.'s profit margins?: Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
What is Fulgent Genetics, Inc.'s earnings per share?: Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
Where does Fulgent Genetics, Inc.'s income statement data come from?: Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.